The latest, most relevant reporting on any medical speciality
Dedicated to supporting all healthcare professionals with information that spans a full range of specialties and disease areas
The medwireNews team’s breadth of knowledge spans a full complement of specialties and disease areas, formed over more than 20 years.
Our team of medical writers and journalists has the expertise needed to select the most relevant and topical information within any therapy area, bringing clinical context and valuable insight to the content we provide.
See below for examples of our content by therapy area. Contact us for more information if your therapy area does not feature.
MEET THE SENIOR TEAM
Lynda Williams
medwireNews Deputy Bureau Chief
Click links below for recent coverage in diabetes:
Click links below for recent coverage in rheumatology:
- EULAR 2025 | Another promising signal for GLP-1 drugs, this time in fibrolyalgia
- EULAR 2025 | POETYK trial shows clinical benefit of deucravacitinib in psoriatic arthritis
- Hemophagocytic lymphohistiocytosis deaths in Europe almost doubled over past decade
- Immunosupressants may not boost belimumab monotherapy in SLE
CClick links below for recent coverage in oncology:
Click links below for recent coverage in haematology:
- ASH 2025 | Reassurance for pregnant SCD patients taking hydroxyurea
- ASH 2025 | Hope B shows ‘durable’ response to hemophilia B gene therapy
- ASH 2025 | First-line fixed-duration CLL regimens noninferior to continuous therapy
- ASH 2025 | MajesTEC-3 supports teclistamab–daratumumab for relapsed/refractory multiple myeloma
Click links below for recent coverage in neurology:
- Moving towards migraine freedom? | Newcomer PACAP could make the difference in migraine control
- EAN 2025 | Early add-on therapy for generalized myasthenia gravis
- EAN 2025 | Nocturnal heart rate variability as a neurological disease marker
- EAN 2025 | CGRP inhibitor benefits for migraine sustained for 2 years
- Tenecteplase improves outcomes in stroke due to basilar artery occlusion
Click links below for recent coverage in endocrinology:
- Cholesterol treatment trialists’ collaboration calls for revision of ‘misleading’ statin labels
- Achondroplasia guidelines outline UK multidisciplinary care throughout childhood
- SGA impaired glucose metabolism exacerbated by growth hormone therapy
- Inclisiran offers additional treatment option for adolescents with HeFH
